TUDCA vs Milk Thistle: Which Is Better for Liver Support?

TUDCA Supplement — NutritionGo

UK-manufactured · 100% Natural · Third-party tested

Shop TUDCA UK

If you're weighing up TUDCA vs milk thistle, they are not direct competitors. They work in different ways.

TUDCA (tauroursodeoxycholic acid) is a bile acid. This guide shows how each one works, what the research says, and which may suit your situation.

Quick Answer: TUDCA is a bile acid. Studies have linked it to bile flow and to mitochondria, the cell's energy centres. Most of that research is in people with bile-flow disorders, such as cholestasis.

Milk thistle (silymarin) is a plant extract. Studies have looked at its antioxidant activity, meaning how it neutralises free radicals. Free radicals are unstable molecules that damage cells. Human results are mixed.

Neither is a "liver detox" product, and neither treats liver disease.

How TUDCA and milk thistle actually differ

TUDCA works within one defined pathway: the bile acid pathway. It gives the body a steady, concentrated dose of a bile acid it already makes. Research has linked this pathway to bile flow and liver-cell health (Kusaczuk, 2019, PubMed).

Milk thistle is studied for a broader antioxidant effect. Its main active compound is silymarin.

It is a general approach, not one aimed at a single pathway. That is why the two are often compared, rather than treated as interchangeable.

TUDCA liver support — what makes it distinct

TUDCA works inside the bile acid pathway. So research on tudca liver support is more specific than for most liver ingredients. That does not make it "stronger". It is just differently targeted, which matters when you choose for your goal.

TUDCA vs Milk Thistle at a Glance

Quick Decision Guide by Goal

What TUDCA and Milk Thistle Actually Are

TUDCA is a bile acid that occurs naturally in small amounts in the body. It is concentrated for supplement use. It is related to ursodeoxycholic acid (UDCA), a medicine already prescribed for some liver and gallbladder conditions.

Milk thistle (Silybum marianum) is a flowering plant. Its seeds contain silymarin, a mix of plant compounds called flavonolignans. Silybin is the most studied of these.

Silymarin extract is what you will usually find standardised in capsules.

In short, TUDCA is a bile acid and milk thistle is a plant extract. Both are sold as food supplements. They work through different biological pathways.

How They Work: Mechanism of Action Compared

TUDCA's Mechanism

In research, TUDCA has been shown to increase bile flow. It also makes other bile acids easier to dissolve, which may lower their harm to liver cells.

It switches on two receptors that help control bile-acid metabolism. FXR is a receptor inside cells that helps regulate bile acids. TGR5 is a bile-acid receptor on the cell surface.

Studies also describe effects on mitochondria, the cell's energy centres. They also describe effects on endoplasmic reticulum (ER) stress in liver cells, called hepatocytes. ER stress is strain in the part of the cell that folds proteins.

This is why most TUDCA research looks at bile stasis and cholestasis, where bile does not flow properly.

Milk Thistle's Mechanism

In lab studies, silymarin acts as an antioxidant and anti-inflammatory. It scavenges free radicals and may help steady cell membranes. Some research has explored effects on the regeneration of damaged liver tissue.

Some laboratory research suggests it can block certain toxins from entering liver cells. Its research focus is oxidative stress, not bile flow.

The Practical Translation

• TUDCA research focuses on bile flow and liver-cell stress in cholestasis.
• Milk thistle research focuses on antioxidant activity and oxidative stress.
• They are not interchangeable. They have different research focuses.

Clinical Evidence: Which Has Better Research?

TUDCA Evidence

TUDCA's strongest human evidence comes from cholestatic liver diseases. These include primary sclerosing cholangitis (PSC), a long-term bile-duct disease, and other bile-acid disorders. In these, it has been studied as a treatment.

For general liver health in healthy people, the evidence is much thinner. It is mostly limited to animal and cell-culture studies.

Milk Thistle Evidence

Milk thistle has centuries of traditional use and a large body of research. But human trial results are inconsistent.

Some studies report modest changes in liver enzymes, and in outcomes linked to cirrhosis or non-alcoholic fatty liver disease (NAFLD). Others find no clear effect compared with a placebo, which is a dummy pill.

Study quality, dose and silymarin standardisation vary widely. That makes the results hard to generalise.

Evidence Grade Comparison

In the UK, food supplements cannot claim to treat or prevent disease. A "detox" claim also needs an authorised health claim, and neither supplement has one. Both need larger, higher-quality human trials.

Evidence Badges by Claim

Dosing, Timing, and Practical Use

Typical TUDCA Dosing

Supplement doses vary by product. Ours provides 400mg per capsule, 1 to 2 capsules a day (up to 800mg). Always follow the label. TUDCA is better absorbed when taken with meals.

Typical Milk Thistle Dosing

Look for extracts standardised to 70–80% silymarin. Typical doses are 140–280 mg, taken one to three times daily.

The standardisation percentage matters more than the raw milligram count on the label.

Timing Notes

Both supplements are usually absorbed better with food. Taking them at the same time each day matters more than exact timing.

This is general supplement guidance, not a personal medical prescription.

Dosing Protocol Blocks

These are general supplement protocols for education. They are not a personalised prescription.

For reference, the UK product information for UDCA, the licensed medicine, says to test the liver every 4 weeks for 3 months. After that, it says every 3 months. This comes from the Ursofalk product information (SmPC) on the emc site. If you take a prescribed liver medicine, follow your clinician's schedule instead.

Safety, Side Effects, and Drug Interactions

TUDCA Safety

TUDCA is generally well tolerated. Mild stomach upset is possible. Avoid it if you have a blocked bile duct.

If you have a hormone-sensitive condition, use caution and ask a clinician first.

Milk Thistle Safety

Milk thistle is also generally well tolerated. Mild digestive symptoms are the most common side effect. Allergic reactions are possible if you are allergic to ragweed-family plants.

It may also interact with certain medicines broken down by CYP450 enzymes, which are liver enzymes that process many drugs. These include some diabetes and cholesterol medicines.

Contraindications and Interactions Checklist

This one list covers both supplements. A contraindication is a reason not to use something.

TUDCA has little direct interaction data. So the TUDCA entries come from the UK product information for UDCA, the closest licensed medicine. Treat them as cautious precautions, not TUDCA-specific findings.

• BothPregnancy and breastfeeding: speak to a healthcare professional first. The NIH says little is known about milk thistle in pregnancy or breastfeeding (NCCIH). The UK label for UDCA says not to use it in pregnancy unless clearly necessary (Ursofalk SmPC (emc)). There is no equivalent safety data for TUDCA.
• BothDiagnosed liver or gallbladder condition, or any prescribed medicine: check with your GP or pharmacist before starting. The NIH gives this advice for milk thistle (NCCIH).
• TUDCABlocked bile ducts, or sudden inflammation of the gallbladder or bile ducts: avoid. These are contraindications on the UDCA label (Ursofalk SmPC (emc)).
• TUDCAFrequent biliary colic (gallbladder pain), calcified gallstones, or poor gallbladder contraction: also contraindications on the UDCA label (Ursofalk SmPC (emc)).
• TUDCAHormone-sensitive conditions and oestrogen-containing medicines: use caution and ask a clinician. The UDCA label says oestrogens can increase gallstone formation (Ursofalk SmPC (emc)).
• TUDCAColestyramine, colestipol and aluminium-containing antacids: they bind bile acids and lower absorption. The UDCA label says to take them at least 2 hours apart (Ursofalk SmPC (emc)).
• TUDCACiclosporin, ciprofloxacin, rosuvastatin, nitrendipine and dapsone: the UDCA label lists interactions with these. Ask a pharmacist before combining (Ursofalk SmPC (emc)).
• Milk thistleRagweed or other daisy-family (aster) allergy: avoid milk thistle. Allergic reactions are possible (NCCIH; American Family Physician).
• Milk thistleMedicines broken down by CYP enzymes: silymarin changed how the body handled losartan, a blood-pressure medicine, in a small study (Han et al., 2009). Ask a pharmacist if you take prescribed medicines.
• BothStop and get advice if diarrhoea or stomach upset persists, symptoms worsen, or your skin or eyes turn yellow. The UDCA label treats persistent diarrhoea as a reason to stop and review (Ursofalk SmPC (emc)).

Cost and Value: Price per Day Compared

• Milk thistle: roughly £0.08–£0.25 per day. It is a widely available, inexpensive generic extract.
• TUDCA: roughly £0.55–£1.50+ per day. It is a costlier, specialised ingredient.

TUDCA costs more per day. Milk thistle usually offers better value if you simply want a lower-cost option.

The "Liver Detox" Myth: Why Both Are Overhyped

Many people search for liver supplements because they want to "detox" the liver. In reality, the liver detoxifies the body all the time. It uses built-in Phase I and Phase II enzyme pathways.

It does not need to be "flushed" or "cleansed" by a supplement. The word "detox" is a marketing idea, not a recognised clinical outcome.

TUDCA and milk thistle are studied for specific processes. TUDCA research looks at bile flow. Milk thistle research looks at antioxidant activity.

If you are evaluating either one, look at what the research actually measured, such as liver enzyme trends. Avoid vague "detox" promises.

Brands like NutritionGo focus on transparent, mechanism-based education rather than detox marketing. That is the direction this category needs to move toward.

Which one should you choose?

If you are interested in the bile acid pathway, TUDCA is the more targeted option. Research on that pathway looks at bile flow, fat digestion and liver-cell health. If you prefer a broader plant-based option, milk thistle is the more established, widely studied choice.

Some people use both together. Talk to a healthcare professional first, rather than assuming more is better.

Choose TUDCA if…

• You have discussed any bile-flow or gallbladder concerns with your GP first.
• You are specifically interested in research on mitochondria and liver cells.
• Budget is not your primary constraint.

Choose Milk Thistle if…

• You want a plant extract studied for antioxidant and anti-inflammatory activity.
• You want an affordable, well-studied option and have checked with your GP first.
• You prefer a long-standing, widely available botanical supplement.

Can You Take Both Together?

Because the two work differently, some people use them together. One is studied for bile-acid regulation. The other is studied for antioxidant activity.

There is no strong evidence of a negative interaction between them. Still, discuss combining supplements with a healthcare provider. This matters most if you take other medicines or have a liver condition.

For a full breakdown of what TUDCA specifically does, see our companion guide: TUDCA Benefits: The Complete UK Guide. If safety and tolerability are your main concern, our TUDCA Side Effects guide covers that in full.

TUDCA Supplement UK – 400mg Capsules

★ 4.67 (3)

£26.99 £34.99

Add to basket

View product details →

TUDCA also sits well alongside our wider range for liver and digestive support.

Shop the range Liver Support supplements Browse 3 products →

The bottom line

TUDCA and milk thistle aren't really "versus". They are two ingredients with different mechanisms. Understanding that difference is more useful than picking a winner.

There is no single "winner" in the TUDCA vs. milk thistle comparison. The better choice depends on your goal.

TUDCA research focuses on bile flow and cholestasis. It has been studied clinically in specific liver conditions. Its general-health evidence is still preliminary.

Milk thistle is a well-established, affordable botanical with a long history of use. Its clinical results remain mixed and depend on dose. Neither is a "liver detox", since the liver already manages detoxification on its own.

Before you start either one, talk to a healthcare provider if you have a liver or bile-flow concern. Check the dose and standardisation on the label.

Used sensibly and with realistic expectations, both are widely sold food supplements. Neither replaces medical advice.

Key Terms in Plain English

• ALT, AST, GGT: Liver enzymes measured in blood tests. Raised levels can signal liver strain.
• Cholestasis: Slowed or blocked bile flow.
• Contraindication: A reason not to use something.
• CYP450: A family of liver enzymes that break down many medicines.
• ER stress: Strain in the part of a cell that folds proteins (the endoplasmic reticulum).
• Free radicals: Unstable molecules that can damage cells. Antioxidants help neutralise them.
• FXR: A receptor that helps regulate bile acids.
• GRADE: A standard system for rating the quality of evidence.
• Hepatocyte: A liver cell.
• Mitochondria: The energy centres inside cells.
• NAFLD: Non-alcoholic fatty liver disease: fat build-up in the liver not caused by alcohol.
• NIH / NCCIH: The US National Institutes of Health, and its National Center for Complementary and Integrative Health.
• Oxidative stress: Cell damage caused by an imbalance of free radicals.
• PBC / PSC: Primary biliary cholangitis and primary sclerosing cholangitis: long-term bile-duct diseases.
• SmPC: Summary of Product Characteristics: the official UK product information for a medicine.
• Standardised extract: An extract made to contain a set percentage of its active compound.
• TGR5: A bile-acid receptor on the surface of cells.
• TUDCA / UDCA: Tauroursodeoxycholic acid and ursodeoxycholic acid: two related bile acids. UDCA is the prescription medicine.

Sources and further reading

1. Kusaczuk M (2019): Tauroursodeoxycholate—bile acid with chaperoning activity: molecular and cellular effects and therapeutic perspectives, Cells 8(12), 1471 — TUDCA as a naturally occurring bile acid formed from UDCA; bile-promoting effects; FXR and TGR5 receptors; endoplasmic reticulum stress and mitochondrial (apoptosis) pathways. The review notes that most evidence is from cell and animal studies and that human data are limited.
2. Ma H et al. (2016): A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis, Medicine 95(47), e5391 — human trial of TUDCA in a cholestatic liver disease (199 adults, 24 weeks); TUDCA was about as effective as UDCA and similarly well tolerated.
3. Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases, Translational Neurodegeneration (2022) — table of human TUDCA trials, including in primary biliary cirrhosis and liver cirrhosis; generally well tolerated, with diarrhoea among the reported adverse events.
4. Song G et al. (2023): Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr/Nrf2 and CHOP-DR5-caspase-8 pathway, Clinical Science 137(7), 561–577 — mouse study of TUDCA in cholestasis (reduced bile acid build-up and liver damage).
5. Ursofalk 500mg film-coated tablets: Summary of Product Characteristics, electronic medicines compendium (emc) — UDCA is a prescription medicine for primary biliary cholangitis and dissolving gallstones; contraindicated in biliary tract occlusion and acute inflammation of the gall bladder or biliary tract; soft stools or diarrhoea are common side effects. This is the licensed UDCA product, not TUDCA.
6. National Center for Complementary and Integrative Health (NIH): Milk thistle: usefulness and safety — clinical trial results for liver conditions are conflicting or too limited to allow conclusions; digestive side effects are the most common; allergic reactions are possible in people allergic to related plants such as ragweed; some products contain amounts of silymarin that differ from the label.
7. Li S et al. (2024): Administration of silymarin in NAFLD/NASH: a systematic review and meta-analysis, Annals of Hepatology 29(2), 101174 — 26 randomised trials (2,375 patients); silymarin was associated with lower ALT and AST in NAFLD.
8. Rainone F (2005): Milk thistle, American Family Physician 72(7), 1285–1292 — products standardised to 80% silymarin and typical trial doses; conflicting trial results in liver disease; gastrointestinal complaints are the most common side effect; avoid with allergies to members of the aster family.
9. Han Y et al. (2009): Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers, European Journal of Clinical Pharmacology 65, 585–591 — silymarin (140 mg three times daily for 14 days) altered losartan metabolism through CYP2C9 in a small crossover study.
10. Surai PF (2015): Silymarin as a natural antioxidant: an overview of the current evidence and perspectives, Antioxidants 4(1), 204–247 — antioxidant and anti-inflammatory effects of silymarin, largely from laboratory and animal studies.
11. Klein AV, Kiat H (2015): Detox diets for toxin elimination and weight management: a critical review of the evidence, Journal of Human Nutrition and Dietetics 28(6), 675–686 — review of the evidence for detox diets.